Hi all
have done a little research into Oakrum Pharma who Marco i imagine would still be involved in some degree being the founder of and found it interesting that they also are involved and looking to expand there range of orphan drugs for rare diseases.
who knows what went down or why ,it will be interesting to see how the MPS deals and partnering eventuates.
For those interested look up Oakrum Pharma rare diseases/orphan drugs
research reports and media, page-3410
-
- There are more pages in this discussion • 781 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
30.0¢ |
Change
-0.010(3.23%) |
Mkt cap ! $104.9M | |||
| Open | High | Low | Value | Volume |
| 31.0¢ | 31.5¢ | 29.0¢ | $161.3K | 527.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 10756 | 30.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.0¢ | 62010 | 3 |
View Market Depth
| Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
| PAR (ASX) Chart |